Blood Pressure Medication Recall: FDA Warns of Potential Cancer-Causing Chemical
The Federal Drug Administration (FDA) has announced a nationwide recall of over 580,000 bottles of a blood pressure medication due to concerns that it may contain a cancer-causing chemical. The recall affects various strengths of prazosin hydrochloride capsules, which are used to treat high blood pressure and are sometimes prescribed for nightmares and other sleep disturbances caused by post-traumatic stress disorder (PTSD).
New Jersey-based drugmaker Teva Pharmaceuticals USA and drug distributor Amerisource Health Services issued the voluntary recall earlier this month, according to the FDA. The affected lots of the recalled drug have been classified as a Class II risk, meaning that they may contain nitrosamine impurities that are considered potentially carcinogenic. These chemicals can form during the manufacturing or storage process, according to the agency.
What You Need to Know About the Recall
The recalled medication comes in 1 mg, 2 mg, and 5 mg doses and is used to relax blood vessels and facilitate blood flow. While the FDA has not received any reports of adverse events related to the recalled medication, the agency is urging consumers to check their medication bottles and consult with their healthcare providers if they have any questions or concerns. Teva Pharmaceuticals has not responded to requests for comment on the recall.
The FDA’s recall notice states that the affected lots of prazosin hydrochloride capsules were distributed nationwide, and consumers can check the agency’s website for a list of the recalled lots. The recall is a precautionary measure to ensure public safety, and the FDA is working with the manufacturers to ensure that the affected medication is removed from the market.
Protecting Public Health
The FDA’s recall of prazosin hydrochloride capsules highlights the importance of ensuring the safety and quality of pharmaceuticals. The agency’s efforts to monitor and regulate the pharmaceutical industry help to protect public health and prevent harm to consumers. By issuing recalls and providing clear guidance to consumers, the FDA is working to minimize the risk of adverse events and ensure that medications are safe and effective.
For more information on the recall, consumers can visit the FDA’s website or consult with their healthcare provider. The FDA also encourages consumers to report any adverse events or concerns related to the recalled medication to the agency’s MedWatch program.
Read more about the recall Here
Image Source: www.cbsnews.com
